Idylla EGFR Mutation Test (CE-IVD) - Abacus dx
Idylla GeneFusion Panel | Biocartis
GeneFusion
IJMS | Free Full-Text | Assessing and Evaluating the Scope and Constraints of Idylla Molecular Assays by Using Different Source Materials in Routine Diagnostic Settings
PDF) Multicenter Evaluation of the Fully Automated PCR-Based Idylla EGFR Mutation Assay on Formalin-Fixed, Paraffin-Embedded Tissue of Human Lung Cancer
Routine workflow used in our laboratory. DNA quality control is... | Download Scientific Diagram
Biocartis Announces Nine Idylla™ Studies Published at AMP 2022 Annual Meeting - Abacus dx
New Study Shows Idylla™ GeneFusion Assay Enables More Rapid Screening of Targetable Fusions - Abacus dx
Patient characteristics and Idylla GeneFusion performance versus... | Download Scientific Diagram
Gene fusions and oncogenic mutations in MLH1 deficient and BRAFV600E wild-type colorectal cancers | SpringerLink
Biocartis poised for European launch of lung cancer screening tool | BioWorld
Biocartis launches Idylla™ GeneFusion Assay as rapid lab workflow solution for gene fusion testing | flanders.bio
IDYLLA™ GENEFUSION ASSAY
Biocartis introduces new Idylla assay for gene fusion testing
Cancers | Free Full-Text | Robust Performance of the Novel Research-Use-Only Idylla GeneFusion Assay Using a Diverse Set of Pathological Samples with a Proposed 1-Day Workflow for Advanced NSCLC Evaluation
TECHNICAL SHEET IDYLLA™ GeneFusion ASSAY
Idylla GeneFusion Panel | Biocartis
GeneFusion
Biocartis Idylla™ GeneFusion Panel - Abacus dx
Idylla GeneFusion Panel | Biocartis
Use of Diagnostic Algorithms for *NTRK* Fusion-Positive Tumors in Pathology Institutes in Switzerland | Published in healthbook TIMES Oncology Hematology
GeneFusion
GeneFusion
Cancers | Free Full-Text | Robust Performance of the Novel Research-Use-Only Idylla GeneFusion Assay Using a Diverse Set of Pathological Samples with a Proposed 1-Day Workflow for Advanced NSCLC Evaluation
